This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Infliximab
REMICADE – Janssen Inc. (NOC Search)
Patents:
- 2146647: HOSPIRA
- 2160630: HOSPIRA
- 2261630: HOSPIRA,
Unknown/Other
- PM(NOC) – A-208-16 – T-1478-15 (2016 FC 525, 2016 FC 651)
HOSPIRA
- Impeachment – T-396-13 (2015 FC 1292, 2016 FC 436, 2018 FC 259, 2018 FC 992, 2021 FC 41, 2021 FC 42, 2018 FC 1067, 2019 FC 1402, 2020 FC 827)
- Appeal – A-252-19 (2020 FCA 177) – A-303-15 (2016 FCA 215) – A-326-16 – A-327-16 – A-328-16 – A-329-18 – A-336-18 (2019 FCA 188) – A-338-18 (2020 FCA 30, 2020 FCA 62) – A-354-18 (2020 FCA 31) – A-360-18 – A-395-19 – A-396-19 (2020 FCA 191) – A-397-19 – A-44-21
- PM(NOC) – A-143-15 (2016 FCA 248) – A-172-15 – T-1516-14
Return to the Patented Medicine Litigation page.